Aprecia Pharmaceuticals, LLC (OH, USA) and Purdue University’s College of Pharmacy (IN, USA) have announced a collaboration to investigate 3D-printed pharmaceuticals.
Having developed the first 3D-printed medication to receive US FDA approval in 2015, the team hopes to combine academic success with industry in combined research and discovery projects.
Aprecia’s mission is to maximize and expand its 3D printing technology platform through global partnerships that will provide pharmaceutical solutions for unmet patient needs,” explained Chris Gilmore, Aprecia CEO.
Purdue University is an esteemed institution, and we are confident that this partnership will advance our future in 3DP pharmaceutical research and development,” Gilmore continued.
Purdue University is committed to its investment in drug discovery and development as well as student and faculty enrichment that will continue to yield global advancement in medicine and healthcare,” added Eric Barker, Dean of Purdue’s College of Pharmacy.
You may also be interested in:
As a College, our mission is to prepare the next generation of leaders in pharmacy. Partnering with Aprecia aligns perfectly with that mission. We are excited to combine our talented students and faculty with the successful researchers at Aprecia to work together to accelerate discoveries in this emerging field,” Barker continued.
Giving our faculty and students access to 3D printing technology through research projects, internships, and joint collaborations advances our mission of educating and training students through scientific discovery and development,” Eric Munson, Head of the Industrial and Physical Pharmacy Department, further commented.
Incorporating the latest technological developments, like 3D printing, into our program are key to producing the best workforce in pharmaceutical formulation and manufacturing,” Munson concluded.